We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Blood is cheap

9 December 2003 By Robert Cyran

The French pharmaceutical company ducks out of the lowmargin, lowgrowth plasma market at a fire sale price. The price does not bode well for Bayer s announced plan to sell its similar business.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)